When is the wording a reason to pause?

FDA registration means a maker has sent its business details to the agency. A drug listing means a product is recorded in the government's searchable drug list. Neither means FDA approval, as checked in September 2026.

An NDC (National Drug Code) provides a number for listing a drug product in a government drug directory. The product's directory number is not proof of FDA approval.

The Federal Trade Commission (FTC) warns that seals or logos on health websites may look official even when they are forged.

Keep a copy of the claim. Ask the person offering care to point to the exact approval record they mean.

Most BPC-157 test sheets FDA reviewed gave only a purity figure—a measure of how much of the tested sample is the intended ingredient. They left out details of tests for unwanted substances, called impurities. This finding was checked in September 2026.

For a medicine given by injection, FDA also identifies tests for germs, harmful substances left by bacteria and stray particles as safety checks. Those harmful substances are called bacterial toxins.

Ask for the full sheet and a plain explanation of its limits. Ask whether it concerns the raw ingredient or the medicine you would receive.

BPC-157 is made in a lab; its link to a stomach-juice protein does not establish safety.

A research-use label describes material offered for laboratory work; it does not make it a medicine for patient care. FDA has not reviewed a BPC-157 product for patient use, as checked in September 2026.

If the offer is to join a study, ask for the study's name, who runs it and the written information for people joining. A label alone does not answer these questions.

Ask for an answer about the exact medicine, rather than a reassuring label.

If a reply changes the subject, restate the question. Ask for the source and a written answer.

If the answer is still unclear, leave the decision open. You can take your notes into another assessment.